mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.6 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.6 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.035 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |